SYS-CON MEDIA Authors: Jayaram Krishnaswamy, Lori MacVittie, Gilad Parann-Nissany, Unitiv Blog, Bob Gourley

News Feed Item

Cortex Submits Application to TSX Venture Exchange for the Issuance of Common Shares for Employee Compensation

CALGARY, ALBERTA -- (Marketwired) -- 12/06/13 -- Cortex Business Solutions Inc. ("Cortex" or the "Company") (TSX VENTURE: CBX), an enterprise eProcurement solutions company, has applied to the TSX Venture Exchange (TSXV) for the issuance of 2,484,200 common shares, which were approved at the June 10, 2013 annual general meeting (AGM).

Out of the 2,484,200 common shares, 100,000 common shares are being distributed as part of the company's hub shares resolution as payment for the signing of significant buying organizations. The remaining 2,384,200 common shares are being distributed to Cortex employees, including insiders, as part of their compensation from employee performance management (EPM) shares, which is based on specific key deliverables and objectives. Both the EPM share and Hub share resolutions were voted on and approved by shareholders at the June AGM. The total shares have been applied to the TSXV for a deemed price of $0.19.

About Cortex Business Solutions

Cortex Business Solutions Inc. (TSX VENTURE: CBX) is an enterprise eProcurement solutions company that improves efficiencies, reduces costs and streamlines procurement and supply chain processes for its customers. Accessing the Cortex Network enhances the exchange of business critical documents, such as purchase orders, receipts and invoices, resulting in improved cash flow management and business controls, while reducing day's outstanding and administrative costs. Cortex is a low cost, low risk solution that can be implemented quickly by leveraging clients' existing business environment. For more information, please visit

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.